Brolucizumab—early real-world experience: BREW study

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Pravin U. Dugel, Adrian Koh, Yuichiro Ogura et al. · Ophthalmology · 2019 · 911 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16

Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab

Caroline R. Baumal, Richard F. Spaide, Lejla Vajzovic et al. · Ophthalmology · 2020 · 303 citations

Medicine, Immunology, Ophthalmology +16

Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration

Sara J. Haug, Doan Luong Hien, Günay Uludağ et al. · American Journal of Ophthalmology Case Reports · 2020 · 142 citations · Full text

Medicine, Ophthalmology, Vision Science +17

Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations

Atul Jain, Sophaktra Chea, Wataru Matsumiya et al. · American Journal of Ophthalmology Case Reports · 2020 · 109 citations · Full text

Medicine, Ophthalmology, Vision Science +17

Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis

Eric H. Souied, Pravin U. Dugel, Alberto Ferreira et al. · Ophthalmic Epidemiology · 2016 · 64 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15